These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6043593)

  • 1. [Experience with the treatment of malignant lymphomas using large single doses of Endoxan].
    Libánský J; Lukásová M
    Vnitr Lek; 1967 Jan; 13(1):30-8. PubMed ID: 6043593
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of large single doses of cyclophosphane (endoxan)].
    Garin AM
    Vopr Onkol; 1970; 16(11):43-8. PubMed ID: 4929048
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of endoxan in malignant granuloma].
    Topolska P; Rostkowska J
    Wiad Lek; 1966 Jan; 19(2):127-30. PubMed ID: 5910345
    [No Abstract]   [Full Text] [Related]  

  • 4. [High dosage cyclophosphamide therapy of malignant diseases in childhood].
    Hempel HC; Grimm J; Naumann UR
    Kinderarztl Prax; 1968 Oct; 36(10):447-54. PubMed ID: 5715803
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnosis, staging, and treatment of the malignant lymphomas.
    Golomb HM; Sweet DL
    Compr Ther; 1980 Jul; 6(7):48-56. PubMed ID: 7471681
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cystitis due to endoxan].
    Vereecken RL; Orshoven AV
    Acta Urol Belg; 1969 Apr; 37(2):131-8. PubMed ID: 5377577
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lymphomas. Treatment of malignant lymphomas. Current observations and future prospects].
    Klastersky J
    Rev Med Brux; 1982 Apr; 3(4):223-34. PubMed ID: 6178138
    [No Abstract]   [Full Text] [Related]  

  • 8. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anaphylactic shock in cyclophosphamide infusion].
    Aulbert E; Kurschel E; Reichenberger M; Schmidt CG
    Med Welt; 1982 Dec; 33(51-52):1845-7. PubMed ID: 7162403
    [No Abstract]   [Full Text] [Related]  

  • 10. [High doses of methotrexate followed by administration of leucovorin in the treatment of malignant lymphomas].
    Klener P
    Vnitr Lek; 1982 Oct; 28(10):997-1002. PubMed ID: 6983181
    [No Abstract]   [Full Text] [Related]  

  • 11. [The so-called partial synchronization in the treatment of malignant lymphomas. A clinical study].
    Höche D; Fink R; Anger G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(1):13-26. PubMed ID: 6157615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy of MOPP and C-MOPP resistant cases of malignant lymphoma. (A preliminary report) (author's transl)].
    Kolarić K; Tomek R; Roth A
    Lijec Vjesn; 1980 Jun; 102(6):306-9. PubMed ID: 7453477
    [No Abstract]   [Full Text] [Related]  

  • 13. Paucity of hematological neoplasia after treatment of Hodgkin disease: observation after long-term follow-up at Cancer Institute, Chennai, south India.
    Sagar TG; Chandra A; Raman SG; Swaminathan R
    Pediatr Hematol Oncol; 2002; 19(3):197-203. PubMed ID: 11936733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experience in the treatment of lymphogranulomatosis with cyclophosphane].
    Glezer GI; Rozhnova EI
    Klin Med (Mosk); 1966 Jan; 44(1):103-7. PubMed ID: 5984408
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment maintaining complete remission in Hodgkin's disease].
    Armata J
    Pol Tyg Lek; 1981 Feb; 36(8):301-4. PubMed ID: 7022410
    [No Abstract]   [Full Text] [Related]  

  • 16. Preparation for marrow transplantation in Hodgkin's and non-Hodgkin's lymphoma using Bu/CY.
    Avalos BR; Klein JL; Kapoor N; Tutschka PJ; Klein JP; Copelan EA
    Bone Marrow Transplant; 1993 Aug; 12(2):133-8. PubMed ID: 8401359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On the problem of the chemotherapeutic prevention of recurrence in malignant lymphogranulomatosis].
    Obrecht P; Musshoff K; Boutis L; Strickstrock KH; Woenckhaus HJ; Ladous A
    Klin Wochenschr; 1968 Apr; 46(7):392-4. PubMed ID: 5686110
    [No Abstract]   [Full Text] [Related]  

  • 18. [Medicinal therapy of malignant lymphomas].
    Aul C; Schroeder M; Giagounidis A
    Radiologe; 2002 Dec; 42(12):943-53. PubMed ID: 12486548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ON CLINICAL TRIALS WITH THE CYTOSTATIC ENDOXAN].
    SCHULTE-BRINKMANN W; HOHN M
    Strahlentherapie; 1963 Aug; 121():625-39. PubMed ID: 14061230
    [No Abstract]   [Full Text] [Related]  

  • 20. [Alternating chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisolone (CHOP); etoposide, procarbazine, vindesine and prednisolone (EPVP) as a treatment for advanced-stage Hodgkin's disease].
    Kumagai K; Takagi T; Sakai C; Wakatsuki S
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):499-501. PubMed ID: 8678506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.